Published in Gene Therapy Weekly, January 23rd, 2003
"Neonates are thought to mount less vigorous adaptive immune responses than adults to antigens and infectious agents," commented Jie Zhang and colleagues at the Scripps Research Institute in La Jolla, California. "This concept has led to a delay in the administration of many currently available vaccines until late infancy or early childhood."
Zhang and collaborators cited previous studies in which vaccination of infants soon after birth with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.